Skip to main content

$0.155 0.005 (3.33%)

High

$0.16

Low

$0.15

Trades

7

Turnover

$4,468

Volume

29,243
30 June 2023 at 3:01pm
Register to track FRE and receive email alerts.

FRE files EU Paediatric Investigation Plan for Nasodine

StockBot

416,823 posts

FRE released this announcement to the ASX on 21 February 2023, 9:16. The announcement is marked as price sensitive, and is 2 page(s) in length and 148.88kb in size.

You can view all announcements from FRE and see how they appear on a price chart on the announcements page.

At the date of this announcement, FRE was 0.006% short sold according to ASIC data. It was ranked the 577th most shorted stock on the ASX. It remains ranked 620th as of the latest reported data (14 July 2025).

Other Recent Announcements from FRE
Firebrick Update on AAT Schedule 29 June 2023, 16:23
Cleansing Notice 21 June 2023, 14:38
Change of Director's Interest Notice - Stephen Goodall 21 June 2023, 14:36
FRE files EU Paediatric Investigation Plan for Nasodine 21 February 2023, 9:16
Appendix 4D & Half Yearly Report and Accounts 17 February 2023, 16:50
Investor Presentation - Euroz Hartleys Healthcare Forum 1 February 2023, 19:32
December 2022 Quarterly Activity Report & Appendix 4C 19 January 2023, 9:22
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track FRE and receive email alerts.